Altimmune
Altimmune focused on the development of products to stimulate robust and durable immune responses for the prevention.
Launch date
Employees
Market cap
AUD780m
Enterprise valuation
AUD528m (Public information from Sep 2024)
Share price
$7.57 ALT
Gaithersburg Maryland (HQ)
Authorizing premium user...